LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
Shao B, Zhao X, Liu T, Zhang Y, Sun R, Dong X, Liu F, Zhao N, Zhang D, Wu L, Wang Y, Wang M, Meng J, Lin X, Sun B.
Shao B, et al. Among authors: meng j.
J Cell Mol Med. 2019 Feb;23(2):1363-1374. doi: 10.1111/jcmm.14039. Epub 2018 Dec 1.
J Cell Mol Med. 2019.
PMID: 30506621
Free PMC article.